Entera Bio Ltd. (ENTX)

Entera Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 15, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	91	78	17	21	81	20
Market Cap Growth	30.25%	351.66%	-17.80%	-74.05%	308.59%	-23.76%
Enterprise Value	81	71	10	7	54	13
Last Close Price	1.97	2.12	0.60	0.73	2.81	1.08
PS Ratio	550.16	431.41	-	156.95	141.91	54.33
PB Ratio	4.43	9.66	1.67	1.79	3.59	2.64
P/TBV Ratio	5.29	9.66	1.67	1.79	3.59	2.64
EV/Sales Ratio	485.97	394.91	-	51.05	94.51	35.56
Debt / Equity Ratio	0.01	0.03	0.04	0.01	0.01	0.06
Asset Turnover	0.01	0.02	-	0.01	0.03	0.03
Quick Ratio	5.89	7.47	10.10	9.36	7.93	4.81
Current Ratio	10.47	7.63	10.32	9.58	8.01	4.95
Return on Equity (ROE)	-82.22%	-103.34%	-80.30%	-76.17%	-81.04%	-115.46%
Return on Assets (ROA)	-44.56%	-56.64%	-44.65%	-43.06%	-42.77%	-52.83%
Return on Capital (ROIC)	-50.28%	-62.64%	-49.13%	-48.52%	-49.57%	-69.25%
Earnings Yield	-11.61%	-12.22%	-51.42%	-62.15%	-15.04%	-56.56%
FCF Yield	-7.33%	-8.73%	-42.38%	-59.65%	-11.21%	-53.50%
Buyback Yield / Dilution	-26.34%	-29.79%	-0.69%	-10.23%	-41.90%	-51.62%

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q